Skip to main content
2025 PALTmed Annual Conference Main banner
Evaluation

Clinical Medicine

(CME115) Breakthrough or Bust? IV Vitamins, Amniotic Membranes, Urine PCR, & Pharmacogenomic Testing

Thursday, March 13, 2025
2:30 PM - 4:00 PM ET
Room: Richardson Ballroom AB
Credits: 1.5
CMD Clinical Credit Recording
CME: (1.5) CMD Clinical: (1.5) NP Pharmacology Hours (0.5)
Session Summary: IV vitamins, amniotic membranes for wound care, urine PCRs, and pharmacogenetic testing (antidepressants & antipsychotics) are some of the new tests and products being utilized in PALTC. The panel of presenters will include a wound care expert and long-term care medical directors. Using a point counterpoint format, the speakers will discuss risks, benefits, efficacy, and indications for each test or therapy. The discussion will include utility of the information obtained through urine PCR and pharmacogenomic testing and evidence-based indications for IV vitamins and amniotic membranes.

Learning Objectives:

At the completion of this session, learners will be able to:
  • Describe scenarios in which amniotic membranes could be considered for chronic wounds.
  • Discuss pros and cons of urine PCR testing and pharmacogenomic testing for antidepressant and antipsychotic medications.
  • Demonstrate an effective conversation regarding the risks and benefits of IV vitamins in nursing home patients.